- Home
- WOR vs VKTX Comparison
WOR vs VKTX Comparison
Compare WOR & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOR
- VKTX
- Stock Information
- Founded
- WOR 1955
- VKTX 2012
- Country
- WOR United States
- VKTX United States
- Employees
- WOR N/A
- VKTX N/A
- Industry
- WOR Aerospace
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- WOR Consumer Discretionary
- VKTX Health Care
- Exchange
- WOR Nasdaq
- VKTX Nasdaq
- Market Cap
- WOR 3.1B
- VKTX 2.8B
- IPO Year
- WOR N/A
- VKTX 2015
- Fundamental
- Price
- WOR $58.38
- VKTX $26.01
- Analyst Decision
- WOR Buy
- VKTX Buy
- Analyst Count
- WOR 3
- VKTX 12
- Target Price
- WOR $57.00
- VKTX $84.00
- AVG Volume (30 Days)
- WOR 185.8K
- VKTX 2.9M
- Earning Date
- WOR 06-24-2025
- VKTX 07-23-2025
- Dividend Yield
- WOR 1.17%
- VKTX N/A
- EPS Growth
- WOR N/A
- VKTX N/A
- EPS
- WOR 1.21
- VKTX N/A
- Revenue
- WOR $1,154,679,000.00
- VKTX N/A
- Revenue This Year
- WOR N/A
- VKTX N/A
- Revenue Next Year
- WOR $3.66
- VKTX N/A
- P/E Ratio
- WOR $48.19
- VKTX N/A
- Revenue Growth
- WOR N/A
- VKTX N/A
- 52 Week Low
- WOR $37.88
- VKTX $18.92
- 52 Week High
- WOR $61.71
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- WOR 49.50
- VKTX 44.01
- Support Level
- WOR $58.83
- VKTX $25.61
- Resistance Level
- WOR $59.85
- VKTX $30.17
- Average True Range (ATR)
- WOR 0.94
- VKTX 1.43
- MACD
- WOR -0.50
- VKTX -0.21
- Stochastic Oscillator
- WOR 8.45
- VKTX 9.76
About WOR Worthington Enterprises Inc.
Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.